| abstract |
The present invention provides novel heterodimeric proteins comprising heterodimeric antibodies. The present invention describes novel immunoglobulin compositions that co-engage antigens simultaneously, wherein the antigens are all monovalently bound. The novel immunoglobulins described preferably utilize Fe regions. Methods of using novel immunoglobulin compositions, particularly for therapeutic purposes, are also described herein. |